Tag

Genmab A/S

1 article

Goldman Upgrades Genmab to Buy, $5bn Upside

Goldman Sachs upgraded Genmab A/S to Buy from Neutral, citing confidence in three pipeline assets with >$5 billion peak‑sales potential through 2026. Shares jumped 2.5% on Copenhagen exchange and near